Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti-CD30/anti-gelonin bispecific antibodies
β Scribed by SABRINA SFORZINI; ANDREA BOLOGNESI; RAFFAFXLA MEAZZA; SABRINA MARCIANO; PATRIZIA CASALINI; HORST DiiRKOp; PIER LUIGI TAZZARI; HARALD STEIN; FIORENZO STIRPE; SILVANO FERRINI
- Book ID
- 114714388
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 575 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Epstein-Barr virus (EBV) can induce uncontrolled B lymphocyte proliferation leading to fatal lymphoma in immunocompromised patients. The sensitivity to apoptosis of B lymphoid cell lines (LCL) derived from EBV-induced lymphoproliferative disorders was investigated. In vitro and in vivo, these B LCL
## Abstract The pathogenesis of Hodgkin's disease (HD) is associated with the accumulation of functionally anergic T cells in the near vicinity of the malignant Hodgkin/ReedβSternberg (H/RS) cell. To stimulate locally the antiβtumour immunity in Hodgkin's disease, we generated an antiβCD30βantibody
We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (